American Society of Clinical Oncology

SHERPA: White

People

  1. Hudis
    Hudis
  2. Dang
    Dang
  3. Modi
    Modi
  4. Norton
    Norton
  5. Iyengar
    Iyengar
  6. Berger
    Berger
  7. Chandarlapaty
    Chandarlapaty
  8. D'Andrea-Carlino
    D'Andrea-Carlino
  9. Goldfarb
    Goldfarb
  10. Lake
    Lake

Groups

  1. Biostatistics Service (12)
  2. Breast Medicine Service (12)
  3. Department of Medicine (12)
  4. Epidemiology and Biostatistics (12)
  5. Solid Tumor Oncology Division (12)
  6. Survivorship Research (11)
  7. Population Sciences Research Program (10)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (9)
  9. GSK Faculty (8)
  10. Human Oncology and Pathogenesis Program (8)
Search Within
  1. "Jose Baselga"
  2. "Biostatistics Service"
  3. "Breast Medicine Service"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (1)
Groups
  1. Biostatistics Service (12)
  2. Breast Medicine Service (12)
  3. Department of Medicine (12)
  4. Epidemiology and Biostatistics (12)
  5. Solid Tumor Oncology Division (12)
  6. Survivorship Research (11)

More Groups

People
  1. Jose Baselga (12)
  2. Clifford Hudis (10)
  3. Sujata Patil (9)
  4. Chau Dang (6)
  5. Larry Norton (6)
  6. Shanu Modi (6)

More People

Years
  1. 2018 (1)
  2. 2017 (2)
  3. 2016 (2)
  4. 2015 (4)
  5. 2014 (3)
Publications
  1. Journal of Clinical Oncology (12)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Longer follow-up on clinical outcomes of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2 overexpressing metastatic breast cancer
    Meeting Abstract

    Wang, R.; Smyth, L. M.; Iyengar, N. M.; Modi, S.; Chandarlapaty, S.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Longer follow-up on cardiac safety and distant disease free survival of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab in patients with early-stage HER2-positive breast cancer
    Meeting Abstract

    Wang, R.; Yu, A. F.; Steingart, R.; Patil, S.; Baselga, J.; Norton, L.; Hudis, C.; Dang, C. T.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Performance of a high-intensity 508-gene circulating-tumor DNA (ctDNA) assay in patients with metastatic breast, lung, and prostate cancer
    Meeting Abstract

    Razavi, P.; Li, B.; Abida, W.; Aravanis, A.; Jung, B.; Shen, R.; Hou, C.; De Bruijn, I.; Gnerre, S.; Lim, R. S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Prevalence of clonal hematopoiesis in patients with advanced cancer
    Meeting Abstract

    Zehir, A.; Coombs, C. C.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D. B.; Robson, M. E.; Baselga, J.; Arcila, M. E.; Tallman, M. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Pilot trial of an implantable microdevice for in vivo drug sensitivity testing in patients with early stage, triple negative breast cancer receiving neoadjuvant therapy
    Meeting Abstract

    Traina, T. A.; Plitas, G.; Reis-Filho, J. S.; Morris, E. A.; Hughes, M.; Sung, J. S.; Patil, S.; Piscuoglio, S.; Park, S.; Greenberg, C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Chandarlapaty, S.; Dickler, M. N.; Ulaner, G.; Zamora, S. J.; Sterlin, V.; Iasonos, A.; Coughlin, C. M.; Morozov, A.; Ero, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Trastuzumab and pertuzumab-based versus other therapy as second-line therapy in HER2-positive metastatic breast cancer: A retrospective study from single center
    Meeting Abstract

    Fontes Santos De Teive Argolo, D.; Smyth, L. M.; Iyengar, N. M.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Journal Article

    Dang, C.; Iyengar, N.; Datko, F.; D'Andrea, G.; Theodoulou, M.; Dickler, M.; Goldfarb, S.; Lake, D.; Fasano, J.; Fornier, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of daily PI3K alpha inhibitor BYL719 plus letrozole (L) or exemestane (E) for patients (pts) with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Modi, S.; Datko, F. M.; Moynahan, M. E.; Zamora, S.; D'Andrea, G.; Lake, D.; Goldfarb, S. B.; Patil, S.; Singh, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save